Market Value360,252,000
Total Holdings124
File Date2021-05-06
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
HSAQ / Health Sciences Acquisitions Corp 2
LSAQ / LifeSci Acquisition II Corp
VSTM / Verastem, Inc.
EVAX / Evaxion A/S - Depositary Receipt (Common Stock)
MICT / M&I Capital Trust B - Preferred Security
LNTH / Lantheus Holdings, Inc.
TVTX / Travere Therapeutics, Inc.
TMPMU / Turmeric Acquisition Corp - Units (1 Ord Share Class A & 1/3 War)
CLDX / Celldex Therapeutics, Inc.
BLU / Bellus Health Inc
ONCT / Oncternal Therapeutics, Inc.
CRIS / Curis, Inc.
CHAQ / Chardan Healthcare Acquisition 2 Corp
EUCRU / Eucrates Biomedical Acquisition Corp
CSTL / Castle Biosciences, Inc.
TCRR / Tcr2 Therapeutics Inc
IMTX / Immatics N.V.
XGN / Exagen Inc.
XENT / Intersect ENT Inc
ARQT / Arcutis Biotherapeutics, Inc.
ILMN / Illumina, Inc.
EPE / Epizyme Inc
MORF / Morphic Holding, Inc.
KDNY / Chinook Therapeutics Inc
FMAC / FirstMark Horizon Acquisition Corp - Class A
AGLE / Aeglea BioTherapeutics Inc
/ Cerevel Therapeutics Holdings, Inc. Warrant
TFFP / TFF Pharmaceuticals, Inc.
GMED / Globus Medical, Inc.
CYTK / Cytokinetics, Incorporated
SLRX / Salarius Pharmaceuticals, Inc.
PRDS / Pardes Biosciences Inc
CTMX / CytomX Therapeutics, Inc.
NMTR / 9 Meters Biopharma Inc
PXS / Pyxis Tankers Inc.
US2103731061 / Constellation Pharmaceuticals Inc
ARYD / ARYA Sciences Acquisition Corp IV
IMUX / Immunic, Inc.
CRDF / Cardiff Oncology, Inc.
NUVA / Nuvasive Inc
CNSP / CNS Pharmaceuticals, Inc.
HAE / Haemonetics Corporation
SCYX / SCYNEXIS, Inc.
OTIC / Otonomy Inc
BCRX / BioCryst Pharmaceuticals, Inc.
GKOS / Glaukos Corporation
IFRX / InflaRx N.V.
VINC / Vincerx Pharma, Inc.
AMHCW / Amplitude Healthcare Acquisition Corp - Warrants (01/12/2026)
CHAQ.WS / Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half (
LYRA / Lyra Therapeutics, Inc.
CHRS / Coherus Oncology, Inc.
JYAC / Jiya Acquisition Corp - Class A
US92731L1145 / Vincerx Pharma, Inc.
SRSAU / Sarissa Capital Acquisition Corp - Units (1 Ord Share Class A & 1/3 War)
US7786732021 / Roth Ch Acquisition II Co.
GLEO.WS / Galileo Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Ordinary Share
NAUT / Nautilus Biotechnology, Inc.
SRZN / Surrozen, Inc.
MGTA / Magenta Therapeutics Inc
GMTX / Gemini Therapeutics Inc
INFI / Infinity Pharmaceuticals Inc.
MCRB / Seres Therapeutics, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
HARP / Harpoon Therapeutics, Inc.
/ EyePoint Pharmaceuticals Inc
US6837121119 / Opendoor Technologies Inc Warrants expiring 12/18/2025
US87105M1100 / Switchback Energy Acquisition Corp Warrants
QTNT / Quotient Ltd
ICUI / ICU Medical, Inc.
OPTN / OptiNose, Inc.
CLRB / Cellectar Biosciences, Inc.
KBNT / Kubient, Inc.
VERO / Venus Concept Inc.
US30258N1211 / WARRANT
WVE / Wave Life Sciences Ltd.
CBIO / Crescent Biopharma, Inc.
BWAY / BrainsWay Ltd. - Depositary Receipt (Common Stock)
CFMS / Conformis Inc.
SMFR / Sema4 Holdings Corp - Class A
VRAY / ViewRay Inc.
US51476H1005 / Landcadia Holdings III, Inc. Class A
GIGGU / GigCapital7 Corp. - Debt/Equity Composite Units
YMTX / Yumanity Therapeutics Inc
EIGR / Eiger BioPharmaceuticals, Inc.
PODD / Insulet Corporation
NBEV / NewAge Inc
HCAQ / HealthCor Catalio Acquisition Corp - Class A
SPNV / Supernova Partners Acquisition Company Inc - Class A
KYG0190X1007 / Ajax I
ADMS / Adamas Pharmaceuticals Inc
QELL / Qell Acquisition Corp - Class A
ACEV / ACE Convergence Acquisition Corp - Class A
MEIP / MEI Pharma, Inc.
FBRX / Forte Biosciences, Inc.
PTGX / Protagonist Therapeutics, Inc.
TNGX / Tango Therapeutics, Inc.
DXCM / DexCom, Inc.
VERB / Verb Technology Company, Inc.
CCAC / CITIC Capital Acquisition Corp - Class A
TILS / TIZIANA LIFE SCIENCES PLC
CALA / Calithera Biosciences, Inc.
BIOR / Biora Therapeutics, Inc.
MYGN / Myriad Genetics, Inc.
BCTX.W / BriaCell Therapeutics Corp. - Equity Warrant
MOTV / Motive Capital Corp - Class A
PHAS / PhaseBio Pharmaceuticals Inc
STRO / Sutro Biopharma, Inc.
ALDX / Aldeyra Therapeutics, Inc.
VRCA / Verrica Pharmaceuticals Inc.
STIM / Neuronetics, Inc.
KALV / KalVista Pharmaceuticals, Inc.
OMEG / Omega Alpha SPAC - Class A
BLSA / BCLS Acquisition Corp - Class A
TWND / Tailwind Acquisition Corp - Class A
VREX / Varex Imaging Corporation
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
RIGL / Rigel Pharmaceuticals, Inc.
IMTXW / Immatics N.V. - Equity Warrant
EYPT / EyePoint Pharmaceuticals, Inc.
CDNA / CareDx, Inc
MBTCU / Nocturne Acquisition Corp - Units (1 Ordinary Shares & 1 Rights)
OEG / Orbital Energy Group Inc
PROF / Profound Medical Corp.
LIFE / aTyr Pharma, Inc.
RNA / Avidity Biosciences, Inc.
OCUL / Ocular Therapeutix, Inc.
AUPH / Aurinia Pharmaceuticals Inc.
CLSN / Imunon Inc
ACET / Adicet Bio, Inc.
CTIC / CTI BioPharma Corp
VLON / Vallon Pharmaceuticals Inc
ISEE / IVERIC bio Inc
NNDM / Nano Dimension Ltd. - Depositary Receipt (Common Stock)
EPIX / ESSA Pharma Inc.
COGT / Cogent Biosciences, Inc.
GNPX / Genprex, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
SYRS / Syros Pharmaceuticals, Inc.
OCUP / Opus Genetics, Inc.
IMVT / Immunovant, Inc.
SMFR / Sema4 Holdings Corp - Class A
AVDL / Avadel Pharmaceuticals plc
NVRO / Nevro Corp.
SIEN / Sientra, Inc.
DYN / Dyne Therapeutics, Inc.
MLTX / MoonLake Immunotherapeutics
ANAB / AnaptysBio, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
INSM / Insmed Incorporated
LRMR / Larimar Therapeutics, Inc.
KPTI / Karyopharm Therapeutics Inc.
ITCI / Intra-Cellular Therapies, Inc.